NB-PP_1170x120

DIR Reform

Pharmacy united in call for President Trump to act on DIR fee reform

Pharmacy united in call for President Trump to act on DIR fee reform

WASHINGTON — Action by the Trump Administration, Congress or both is needed now to provide relief from pharmacy direct and indirect remuneration (DIR) fees that inflate drug costs paid by patients and the government, and that force pharmacies to fill Medicare prescriptions often below cost. That was the message delivered Monday in a letter to

The fight over DIR reform goes on

The fight over DIR reform goes on

The community pharmacy profession was blindsided by the Trump administration last month when the Department of Health and Human Services issued the final rule that will govern the Medicare Part D and Medicare Advantage programs in 2020. In a radical departure from the proposed rule released earlier in the year, the eventual regulation offered no

NACDS RxIMPACT rallies senate support for action on DIR fees

NACDS RxIMPACT rallies senate support for action on DIR fees

ARLINGTON, Va. – The National Association of Chain Drug Stores (NACDS) RxIMPACT grassroots advocacy program has mobilized to support a U.S. Senate initiative urging action by U.S. Secretary of Health and Human Services Secretary Alex Azar on direct and indirect remuneration (DIR) fee reform in Medicare Part D. NACDS RxIMPACT pharmacy advocates are urging Senators to